Valuation (21%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -5.96 | N/A |
| PEG Ratio (TTM) | -0.11 | N/A |
| P/S Ratio (TTM) | 0.15 | N/A |
| P/B Ratio (TTM) | 1.39 | N/A |
| P/FCF Ratio (TTM) | N/A | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -7.56% | N/A |
| ROE (TTM) | -22.85% | N/A |
| Net Profit Margin (TTM) | -2.47% | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (10%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -0.97% | N/A | N/A |
| Revenue | 1.05% | N/A | N/A |
| Net Income | 46.55% | N/A | N/A |
| Cash Flow | -42.00% | N/A | N/A |
Health (23%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.43 | N/A |
| Quick Ratio (TTM) | 1.43 | N/A |
| D/E Ratio (TTM) | 0.04 | N/A |
| Interest Coverage (TTM) | -91.60 | N/A |
| Piotroski F-Score | 3 | N/A |
| Altman Z-Score | 0.43 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |